22-02-2026 02:46 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Historical Volume
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 379.18
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 673584.68
P/E 31.61
EPS 36.69
Face Value 1  
Exchange : Period From : To :
DateOpen PriceHigh PriceLow PriceClose PriceVolumeTurnover
20-Feb-2026 1170.00 1175.60 1149.55 1159.75 28911 33640046
19-Feb-2026 1158.95 1201.00 1158.00 1175.75 122879 145884963
18-Feb-2026 1186.45 1193.15 1130.00 1159.75 95224 109801654
17-Feb-2026 1186.25 1212.60 1168.25 1184.65 88499 105552481
16-Feb-2026 1133.90 1187.00 1133.90 1184.90 121222 142587589
13-Feb-2026 1154.85 1157.10 1127.30 1148.50 16694 19116341
12-Feb-2026 1146.00 1160.90 1134.00 1157.55 14398 16513072
11-Feb-2026 1138.40 1160.70 1124.90 1146.00 151519 173456052
10-Feb-2026 1207.85 1218.20 1106.25 1122.35 270367 308068141
09-Feb-2026 1181.20 1210.00 1171.45 1201.25 24481 29228405
06-Feb-2026 1174.75 1195.00 1166.40 1191.15 11909 14014755
05-Feb-2026 1225.25 1225.25 1178.00 1182.50 14132 16788244
04-Feb-2026 1226.15 1238.60 1166.90 1211.70 50623 60930738
03-Feb-2026 1247.05 1247.05 1210.85 1226.15 268352 329487562
02-Feb-2026 1169.50 1190.00 1153.80 1175.10 6613 7721565
01-Feb-2026 1215.00 1215.00 1165.00 1168.90 25858 30692959
Page 1 of 1
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.